Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2006-03-21
2006-03-21
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S194100, C424S193100, C424S203100, C424S234100, C424S241100, C424S184100, C536S123100, C530S807000
Reexamination Certificate
active
07014857
ABSTRACT:
The present invention provides an immunogenic conjugate comprising biologically deacylated gram-negative bacterial moieties linked toD. discoideumproteinase 1, as well as novel subunits thereof, and methods of making and using the conjugates in vaccines to treat sepsis and other infectious complications.
REFERENCES:
patent: 4771127 (1988-09-01), Cryz et al.
patent: 5306492 (1994-04-01), Porro
patent: 5370872 (1994-12-01), Cryz et al.
patent: 5445817 (1995-08-01), Schneerson et al.
patent: 5573916 (1996-11-01), Cheronic et al.
patent: 5736146 (1998-04-01), Cohen et al.
patent: 5785973 (1998-07-01), Bixler et al.
patent: 5866132 (1999-02-01), Malcolm
patent: 5869058 (1999-02-01), Cohen et al.
patent: 6531131 (2003-03-01), Gu et al.
patent: 6645503 (2003-11-01), Arumugham et al.
patent: 2005/0147624 (2005-07-01), Jennings et al.
patent: 0941738 (1999-09-01), None
patent: WO-93/03765 (1993-03-01), None
patent: WO-93/13797 (1993-07-01), None
patent: WO-94/05325 (1994-03-01), None
The Webster's II New Riverside University Dictionary, The Riverside Publishing Company, p. 933, 1984.
Illustrated Stedman's Medical Dictionary, 24thEdition, Williams & Wilkins, Balitmore/London, p. 707, 1982.
Schneerson et al. Infect. Immun. 45: 582-591, 1984.
“Outbreaks of Salmonella Serotype Enteritidis Infection Associated with Eating Raw Undercooked Shell Eggs—United States, 1996-1998”,CDC, MMWR, Morbidity and Mortality Weekly Report, (2000),pp. 1132-1134.
Ames, B., “Assay of Inorganic Phosphate, Total Phosphate and Phosphatases”,In: Analytical Methods, (1966),pp. 115-118.
Ashwell, G.,et al. , “A Colorimetric Procedure for the Determination of N-Acetylated-3-Amino Hexoses”,Archives of Biochemistry and Biophysics, 112, (1965),pp. 648-652.
Bahrami, S.et al. , “Monoclonal antibody to endotoxin attenuates hemorrhage-induced lung injury and mortality in rats”,Critical Care Med., 25(6), (1997),pp. 1030-1036.
Bailat, S.,et al. , “Similarities and Disparities between Core-Specific and O-Side-Chain-Specific Antipopolysaccharide Monoclonal Antibodies in Models of Endotoxemia and Bacteremia in Mice”,Infection and Immunity, 65(2), (1997),pp. 811-814.
Barriere, S.,et al. , “An overview of mortality risk prediction in sepsis”,Critical Care Medicine, 23(2), (1995),pp. 376-378, 383-388, 393.
Bergquist, C.,et al. , “Anticarrier Immunity Suppresses the Antibody Response to Polysaccharide Antigens after Intranasal Immunization with the Polysaccharide-Protein Conjugate”,Injection and Immunity, 65(5), (1997),pp. 1579-1583.
Bhattacharjee, A.,et al. , “A Noncovalent Complex Vaccine Prepared with DetoxifiedEscherichia coliJ5 (Rc Chemotype) Lipopolysaccharide and Neisseria meningitidis Group B Outer Membrane Protein Produces Protective Antibodies against Gram-Negative Bacteremia”,The Journal of Infectious Diseases, 173, (1996),pp. 1157-1163.
Bhattacharjee, A.et al. , “Affinity-PurifiedEscherichia coliJ5 Lipopolysaccharide-Specific IgG Protects Neutropenic Rats against Gram-Negative Bacterial Sepsis”,The Journal of Infectious Diseases, 170, (1994),pp. 622-629.
Blanque, R.,et al. , “Hypothermia as an Indicator of the Acute Effects of Lipopolysaccharides: Comparison with Serum Levels of IL1beta, IL6 and TNFalpha”,Gen. Pharmac., 27(6), (1996),pp. 973-977.
Bone, R.,et al. , “The Patogenesis of Sepsis”,Annals of Internal Medicine, 115, (1991),pp. 457-469.
Braude, A.,et al. , “Antibody to Cell Wall Glycolipid of Gram-Negative Bacteria: Induction of Immunity to Bacteremia and Endotoxemia”,The Journal of Infectious Diseases, 136, (1977),pp. S167-S173.
Braude, A.,et al. , “Treatment and Prevention of Intravascular Coagulation with Antiserum Endotoxin”,The Journal of Infectious Diseases, 128, (1973),pp. S157-S163.
Cohen, D.,et al. ,“Safety and Immunogenicity of Investigational Shigella Conjugate Vaccines in Israeli Volunteers”,Infection and Immunity, 64(10), (1996),pp. 4074-4077.
Di John, D.,et al. ,“Effect of Priming with the Carrier on Response to Conjugate Vaccine”,The Lancet, (1989),pp. 1415-1418.
Di Padova, F.,et al. ,“A Broadly Cross-Protective Monoclonal Antibody Binding toEscherichia coliand Salmonella Lipopolysaccharides”,Infection and Immunity, 61(9), (1993),pp. 3863-3872.
Driscoll, D.M. ,et al. , “Two Divergently Transcribed Genes of Dictyostelium discoideum are Cyclic AMP-inducible and Coregulated During Development”,Mol. Cell. Bio., 7, (1987),4482-4489.
Finn, D.,et al. ,“Antibodies that Recognize Phosphodiester-Linked alpha-N-Acetylgucosamine-1-Phosphate Residues”,Biochemical and Biophysical Research Communications, 148(2), (1987),pp. 834-837.
Flak, T.,et al. ,“Muramyl Peptide Probes Derived from Tracheal Cytotoxin ofBordetella pertussis”,Analytical Biochemistry, 264, (1998),pp. 41-46.
Galanos, C.,et al. ,“A New Method for the Extraction of R Lipopolysaccharides”,European J. Biochem., 9, (1969),pp. 245-249.
Galanos, C.,et al. ,“Mechanism of Endotoxin Shock and Endotoxin Hypertensensitivity”,Immunobiol., 187, (1993),pp. 346-356.
Galanos, C.,et al. ,“Synthetic and naturalEscherichia colifree lipid A express identical endotoxic activities”,Eur. J. Biochem., 148, (1985),pp. 1-5.
Geerdes, H..,et al. ,“Septicemia in 980 Patients at a University Hospital in Berlin: Prospective Studies During 4 Selected Years Between 1979 and 1989”,Clinical Infectious Diseases, 15, (1992),pp. 991-1002.
Good, T.,et al. , “Determination of Glucosamine and Galactosamine Using Borate Buffers for Modification of the Elson-Morgan and Morgan-Elson Reactions”,Analytical Biochemistry, 9, (1964),pp. 253-262.
Gu, X.,et al. ,“Synthesis, Characterization, and Immunologic Properties of Detoxified Lipooligosaccharide from Nontypeable Haemophilus influenza Conjugated to Proteins”,Infection and Immunity, 64(10), (1996),pp. 4047-4053.
Gupta, R.,et al. , “Comparative Immunogenicity of Conjugates Composed ofEscherichia coliO111 O-Specific Polysaccharide, Prepared by Treatment with Acetic Acid or Hydrazine, Bound to Tetanus Toxoid by Two Synthetic Schemes”,Infection and Immunity, 63(8), (1995),pp. 2805-2810.
Gupta, R.,et al. ,“Synthesis, Characterization, and Some Immunological Properties of Conjugates Composed of the Detoxified Lipopolysaccharide ofVibrio choleraeO1 Serotype Inaba Bound to Cholera Toxin”,Infection and Immunity, 60(8), (1992),pp. 3201-3208.
Gustafson, G.,et al. ,“Monophosphoryl Lipid A as a Prophylactic for Sepsis and Septic Shock”,Bacterial Endotoxins: Lipopolysaccharides from Genes to Therapy, (1995),pp. 567-579.
Gustafson, G.,et al. ,“Occurence of N-Acetylglucosamine-1-phosphate in Proteinase I from Dictyostelium discoideum”,The Journal of Biological Chemistry, 255(15), (1980),pp. 7208-7210.
Gustafson, G..,et al. ,“Purification and Characterization of a Proteinase from Dictyostelium discoideum”,The Journal fo Biological Chemistry, 254(24), (1979),pp. 12471-12478.
Hase, S.,et al. ,“Isolation and Analysis of the Lipid A Backbone”,European Journal of Biochemistry, 63, (1976),pp. 101-107.
Herzenberg, L.,et al. ,“Carrier-priming leads to hapten-specific suppression”,Nature, 285, (1980),pp. 664-667.
Hoffman, W.,et al. ,“Endotoxin in Spetic Shock”,Anesth Analg., 77, (1993),pp. 613-624.
Johnson, K.,et al. , “Improved techniques for the preparation bacterial lipopolysaccharides”,Can. J. Microbiol., 22, (1976),pp. 29-34.
Konadu, E.,et al. ,“Investigational Vaccine forEscherichia coliO157: Phase 1 Study of O157 O-Specific Polysaccharide-Pseudomonas aeruginosa Recombinant Exprotein A Conjugates in Adults”,Journal of Infectious Diseases, 177, (1998),pp. 383-387.
Konadu, E.,et al. , “Phase 1 nad Phase 2 Studies ofSalmonella entericaSerovar Paratyphi A O-Specific P
DeBorde Dan C.
Gustafson Gary L.
Devi S.
EndoBiologics, Incorporated
Schwegman, Lundberg, Woessner and Kluth P.A.
LandOfFree
Anti-sepsis conjugate vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-sepsis conjugate vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-sepsis conjugate vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3591591